Peptides modified by oxidation, phosphorylation, or acetylation were identified and, with few exceptions, were substantially enriched in Aβ1–42‐ and tau‐affinity pulldowns from AD (Table 1, colored numbers, summarized in the bottom rows and in Fig. S1; see also (Boyd‐Kimball et al., 2006)). This evidence concerns the gene MAPT and Alzheimer disease.